- Study focused on gene therapy vs. cochlear implants for congenital deafness.
- Participants included 72 children with OTOF variants.
- Gene therapy showed quicker improvements at 6 months.
- Cochlear implants had better hearing thresholds at 12 months.
- Bimodal patients performed better on specific tasks.
- Study limitations include small sample size and potential biases.
- Long-term effects and broader applicability of gene therapy remain uncertain.
- Recommendations for larger studies on various genetic causes.
Source: JAMA Neurology
